GB001 is a potent, insurmountable DP2 antagonist with long receptor residence time and extended pharmacodynamic effects

Autor:	Hector Ortega, Laura Carter, Sunil Sahdeo, Terry Kenakin, Tomas Salter-Cid, Gregory J. Opiteck, Susan Murphy, Sam Hoare, Kristen Taylor Meadows, Luisa Salter-Cid
Rok vydání:	2020
Předmět:	business.industry Pharmacodynamics Antagonist Medicine Pharmacology Residence time (fluid dynamics) business Receptor
Zdroj:	Airway pharmacology and treatment.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d3825b75d4e0b8ff76f4fae03a4069a0 https://doi.org/10.1183/13993003.congress-2020.1420 Zobrazit plný text záznamu